Oramed to Present at H.C. Wainwright Global Investment Conference

NEW YORK , May 18, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq:ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present an in-person

Join our mailing list

Skip to content